Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid tumor treatment workshop summary

P S Gill1, D Parkinson

  • 1University of Southern California, School of Medicine, Department of Internal Medicine, Los Angeles.

Leukemia
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mistaking a Tumour for an Infection - Acrometastasis of the Finger from Endocervical Adenosquamous Carcinoma: A Case Report.

Malaysian orthopaedic journal·2021
Same author

Diagnosis of osteoarticular tuberculosis by immuno-PCR assay based on mycobacterial antigen 85 complex detection.

Letters in applied microbiology·2021
Same author

Reply by Authors.

The Journal of urology·2020
Same author

Association between Smoking Exposure, Neoadjuvant Chemotherapy Response and Survival Outcomes following Radical Cystectomy: Systematic Review and Meta-Analysis.

The Journal of urology·2020
Same author

Genetic structure of three populations of rhesus macaques (Macaca mulatta): Implications for genetic management.

American journal of primatology·2020
Same author

Carbohydrate restriction for glycaemic control in Type 2 diabetes: a systematic review and meta-analysis.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same journal

Linperlisib enhances MUC1-Tn CAR T cell efficacy by inhibiting EGR1/DUSP2 axis to prevent CAR T cell exhaustion.

Leukemia·2026
Same journal

CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemia.

Leukemia·2026
Same journal

Single-cell architecture of purinergic signaling in human cord blood hematopoietic stem and progenitor cells.

Leukemia·2026
Same journal

Feasibility and safety of rapid glofitamab ramp-up.

Leukemia·2026
Same journal

Single-cell DNA methylation analysis uncovers epigenetic pathways in the transformation of MDS to AML.

Leukemia·2026
Same journal

PD-L2 is associated with lineage-related transcriptional programs distinct from PD-L1 in primary mediastinal large B-cell lymphoma.

Leukemia·2026
See all related articles

Retinoic acids (RAs) impact tumor cells via nuclear receptors, influencing differentiation, proliferation, and apoptosis. Further research is needed to understand receptor roles and optimize RA combination therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • Retinoic acids (RAs) exhibit diverse biological activities by interacting with nuclear receptors, including RARs and RXRs.
  • RAs induce significant effects on tumor cells, such as promoting cell differentiation, inhibiting proliferation, and triggering apoptosis.

Framework:

  • The precise roles and expression patterns of individual retinoic acid receptor subtypes (RAR-alpha, beta, gamma; RXR-alpha, beta, gamma) are under active investigation.
  • Understanding the mechanisms behind RA efficacy in specific cancers like skin and cervical cancer is crucial for optimizing their therapeutic use.

Implementation:

  • Investigating drug-drug interactions is vital, focusing on pharmacokinetic changes, receptor modulation, and the regulation of cytoplasmic retinoic acid-binding proteins (CRABPs).

Related Experiment Videos

  • Pre-clinical and clinical trials must carefully evaluate these interactions to ensure safe and effective RA-based treatments.

    • Implications:

    • Developing appropriate models is essential for studying combinations of RAs with other biological response modifiers.
    • This research aims to enhance the clinical utility of retinoic acids in cancer therapy through a deeper understanding of their mechanisms and interactions.